Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol on HRV in T2DM Anesthesia
NCT06009055Recruiting
- Start
- Sep 2023
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam (2 arms). Primary endpoints: Systolic Blood Pressure at 24 hours, Diastolic Blood Pressure at 24 hours and 2 more. Started Sep 2023; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT06009055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06009055.